Stocks News

LAST PRICE
357.3200
TODAY'S CHANGE (%)
Trending Down-0.4000 (-0.1118%)

Bid / Lots
356.8200/ 2
Ask / Lots
357.5200/ 4
Open / Previous Close
359.8200 / 357.7200
Day Range
Low 356.8900
High 360.7900
52 Week Range
Low 208.6249
High 366.0800
Volume
50,057
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Sep 24, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
  7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Human pharmacokinetic studies with an oral formulation of treprostinil (treprostinil diolamine) indicated that co-administration of the cytochrome P450 (CYP) 2C8 enzyme inhibitor, gemfibrozil, increases exposure (both C(max) and AUC) to treprostinil. Co-administration of the CYP2C8 enzyme inducer, rifampin, decreases exposure to treprostinil. It is unclear if the safety and efficacy of treprostinil by the inhalation route are altered by inhibitors or inducers of CYP2C8.
Sep 23, 2024
- DJ United Therapeutics Is Maintained at Buy by Jefferies, from 11:30AM ET on Monday Sep 23, 2024 by Dow Jones
  11:30AM ET on Monday Sep 23, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  September 23, 2024 11:30 ET (15:30 GMT)
Sep 16, 2024
- Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million, from 2:17PM ET on Monday Sep 16, 2024 by MT Newswires
  2:17PM ET on Monday Sep 16, 2024 by MT Newswires
  Companies Mentioned: NVS, UTHR, LQDA
  02:17 PM EDT, 09/16/2024 (MT Newswires) -- Liquidia (LQDA) shares were climbing over 1% Monday after a federal judge sided with the biopharmaceutical company and a partner firm in their legal fight alleging United Therapeutics (UTHR) interfered with...
- DJ Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M, from 10:34AM ET on Monday Sep 16, 2024 by Dow Jones
  10:34AM ET on Monday Sep 16, 2024 by Dow Jones
  Companies Mentioned: UTHR, LQDA
  
  By Don Nico Forbes
  
  Liquidia said a U.S. court determined losses caused by interference from United Therapeutics during the launch of its generic Treprostinil Injection were in excess of $137 million.
Sep 10, 2024
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind--Ever, from 7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
  7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Report available at corporateresponsibility.unither.com
  SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--September 10, 2024--
  United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2024 Corporate Responsibility and Public Benefit Report (Report) covering its FY 2023 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of patients and other stakeholders.

Today
- DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: NBIX, ABBV, BMY
- DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: NBIX, ABBV, BMY
Yesterday
- Qiagen Gets European Certification for Syndromic Testing Systems, from 19 hours ago by MT Newswires
  19 hours ago by MT Newswires
  Companies Mentioned: QGEN
- QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays, from 20 hours ago by Dow Jones
  20 hours ago by Dow Jones
  Companies Mentioned: QGEN
Sep 25, 2024
- PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples, from 4:05PM ET on Wednesday Sep 25, 2024 by Dow Jones
  4:05PM ET on Wednesday Sep 25, 2024 by Dow Jones
  Companies Mentioned: QGEN
Sep 23, 2024
- QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database, from 4:05PM ET on Monday Sep 23, 2024 by Dow Jones
  4:05PM ET on Monday Sep 23, 2024 by Dow Jones
  Companies Mentioned: QGEN
- DJ S&P 500 Futures Up In Premarket Trading; Simpson Manufacturing, Intel Lead, from 7:30AM ET on Monday Sep 23, 2024 by Dow Jones
  7:30AM ET on Monday Sep 23, 2024 by Dow Jones
  Companies Mentioned: EXAS, INTC, MTH, RDN, SSD, GM, CIEN
Sep 19, 2024
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  4:01PM ET on Thursday Sep 19, 2024 by PR Newswire
  Companies Mentioned: NBIX
- Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  4:01PM ET on Thursday Sep 19, 2024 by Dow Jones
  Companies Mentioned: NBIX
- Qiagen Launches 100 New Assays for QIAcuity Platform, from 5:37AM ET on Thursday Sep 19, 2024 by MT Newswires
  5:37AM ET on Thursday Sep 19, 2024 by MT Newswires
  Companies Mentioned: QGEN

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

Sep 24, 2024

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones

Sep 23, 2024

DJ United Therapeutics Is Maintained at Buy by Jefferies, from 11:30AM ET on Monday Sep 23, 2024 by Dow Jones

Sep 16, 2024

Liquidia Says United Therapeutics' Interference Found by US Court to Have Caused Losses of Over $137 Million, from 2:17PM ET on Monday Sep 16, 2024 by MT Newswires

DJ Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M, from 10:34AM ET on Monday Sep 16, 2024 by Dow Jones

Sep 10, 2024

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind--Ever, from 7:00AM ET on Tuesday Sep 10, 2024 by Dow Jones

Peers Headlines

Today

DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 2 hours ago by Dow Jones

DJ Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking. -- Barrons.com, from 3 hours ago by Dow Jones

Yesterday

Qiagen Gets European Certification for Syndromic Testing Systems, from 19 hours ago by MT Newswires

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays, from 20 hours ago by Dow Jones

Sep 25, 2024

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples, from 4:05PM ET on Wednesday Sep 25, 2024 by Dow Jones

Sep 23, 2024

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database, from 4:05PM ET on Monday Sep 23, 2024 by Dow Jones

DJ S&P 500 Futures Up In Premarket Trading; Simpson Manufacturing, Intel Lead, from 7:30AM ET on Monday Sep 23, 2024 by Dow Jones

Sep 19, 2024

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by PR Newswire

Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual Summit, from 4:01PM ET on Thursday Sep 19, 2024 by Dow Jones

Qiagen Launches 100 New Assays for QIAcuity Platform, from 5:37AM ET on Thursday Sep 19, 2024 by MT Newswires